Turner syndrome is diagnosed through a chromosome test called a karyotype analysis, which confirms that one of the two X chromosomes is missing or partially missing. But the path to that test varies widely depending on age. Some cases are caught before birth through prenatal screening, others are identified in newborns with telltale physical features, and a significant number aren’t discovered until a girl falls behind on growth or doesn’t start puberty on schedule.
Prenatal Screening and Confirmation
Turner syndrome can be flagged during pregnancy through several screening methods available at different stages. First trimester screening, performed between weeks 11 and 13, combines a blood test with a nuchal translucency ultrasound that measures fluid at the back of the fetal neck. Increased fluid can signal chromosomal differences. Noninvasive prenatal testing (NIPT), a blood draw that analyzes fragments of fetal DNA circulating in the mother’s blood, can also detect signs of Turner syndrome during this window.
NIPT is a screening tool, not a diagnostic one. For Turner syndrome specifically, its positive predictive value is notably low, around 19% in one large study. That means roughly four out of five positive NIPT results for Turner syndrome turn out to be false alarms. This is much less reliable than NIPT’s accuracy for conditions like Down syndrome, so a positive screen always requires confirmation through a diagnostic procedure.
The two confirmatory tests are chorionic villus sampling (CVS), available around weeks 10 to 13, and amniocentesis, typically performed between weeks 15 and 20. Both collect fetal cells for a full karyotype analysis that can definitively identify a missing or altered X chromosome. If prenatal ultrasounds reveal certain findings, such as a cystic hygroma (a fluid-filled swelling at the neck), heart defects, or kidney abnormalities, providers may recommend these diagnostic tests even without a prior screening flag.
Signs That Lead to Diagnosis in Newborns
When Turner syndrome isn’t identified before birth, certain physical features in a newborn can prompt testing. Swollen hands and feet caused by fluid buildup (lymphedema) are among the most recognizable early signs. Webbed skin on the sides of the neck, widely spaced nipples, and low-set ears also raise suspicion. Heart defects are another common trigger. A bicuspid aortic valve, where the main heart valve has two flaps instead of three, and coarctation of the aorta, a narrowing of the body’s largest blood vessel, occur frequently in Turner syndrome and may be detected shortly after birth.
Not all newborns with Turner syndrome have obvious physical features. Girls with mosaic forms, where only some cells are missing an X chromosome, often look typical at birth and are diagnosed later.
Growth Delays and Childhood Diagnosis
The most common reason for a Turner syndrome diagnosis during childhood is short stature. Girls with Turner syndrome grow more slowly than their peers starting around age two or three, and the gap widens over time. Unexplained short stature alone is considered enough reason to order a karyotype, even without other features. The average adult height for women with untreated Turner syndrome is about 4 feet 8 inches.
Genetic testing is also recommended when short stature appears alongside at least two other features from a specific cluster: kidney abnormalities like horseshoe kidney, a wrist bone deformity called Madelung deformity, congenital heart defects, unusually curved or thick nails, multiple raised moles, early hearing loss, or neuropsychological challenges. Any of these combinations should prompt chromosomal evaluation, even if the girl’s height isn’t dramatically below average.
Diagnosis During Puberty and Adulthood
A substantial number of Turner syndrome cases aren’t caught until puberty fails to begin or progress normally. The classic presentation is a teenage girl who hasn’t started her period by age 15 (primary amenorrhea) or who begins developing breasts but then stalls. In Turner syndrome, the ovaries typically lose their eggs at an accelerated rate, sometimes as early as 18 weeks into fetal development. By the time puberty should start, most girls with the condition have very little functional ovarian tissue left.
Blood tests at this stage reveal a pattern called hypergonadotropic hypogonadism. The brain’s signaling hormones, FSH and LH, are elevated because the pituitary gland keeps trying to stimulate ovaries that can’t respond. During early and middle childhood, FSH levels above the normal prepubertal range can be an early clue even before puberty is expected. One research group has suggested that FSH monitoring could help identify Turner syndrome earlier, before the typical delay in puberty becomes apparent.
Some women aren’t diagnosed until adulthood, when they seek help for infertility or premature ovarian insufficiency. In these cases, a karyotype is often ordered after elevated FSH levels and low estrogen point toward ovarian failure that can’t be explained by other causes.
The Karyotype: The Definitive Test
Regardless of what triggers suspicion, the diagnosis of Turner syndrome is confirmed through karyotype analysis. This test examines chromosomes from a blood sample, typically analyzing 20 to 30 cells. The classic finding is 45,X, meaning only one X chromosome is present. This accounts for roughly 40 to 56% of cases, depending on the study.
The remaining cases involve variations. About 15 to 25% of women have mosaicism, where some cells are 45,X and others are normal 46,XX. Another 10% have an isochromosome, where one arm of the X chromosome is duplicated while the other is deleted. Rarer patterns include ring chromosomes (about 7% of cases) and the presence of Y chromosome material (3 to 10%). These distinctions matter because different karyotypes influence how the condition affects the body. Women with mosaicism, for instance, tend to have milder features and are more likely to go through some spontaneous puberty.
When Standard Karyotyping Misses the Full Picture
A standard karyotype examines a limited number of cells, which means it can miss low-level mosaicism. A girl might test as straightforward 45,X on a 20-cell analysis when she actually has a small percentage of cells with a different chromosome makeup. This is where FISH (fluorescence in situ hybridization) testing becomes valuable. FISH uses fluorescent probes that bind to specific chromosomes and can scan hundreds of cells quickly.
In one study, FISH analysis identified hidden sex chromosome mosaicism in 37% of patients who appeared to have non-mosaic 45,X on standard karyotyping. That’s a significant proportion, and it changes clinical management. For example, identifying even a small percentage of cells carrying Y chromosome material is important because it carries a slightly increased risk of gonadal tumors, which may require monitoring or preventive surgery. Many genetics labs now use FISH as a routine add-on whenever a 45,X result is found on standard karyotyping, and newer chromosomal microarray (SNP array) technology can catch even more subtle variations.
What Happens After Diagnosis
A confirmed diagnosis triggers a specific set of evaluations to check for associated health conditions, many of which cause no symptoms initially. A complete echocardiogram is recommended for every patient, even if a fetal echocardiogram looked normal during pregnancy. Certain heart abnormalities in Turner syndrome can be clinically silent and only detectable with dedicated imaging. Coronary artery anatomy should also be visualized at the first encounter, using echocardiography in infants or cardiac MRI or CT in older patients and adults.
Kidney imaging, a hearing evaluation, and thyroid function testing are also standard parts of the initial workup. About 30% of girls with Turner syndrome have kidney abnormalities, and thyroid problems develop in roughly 25% over time. These baseline tests establish what, if anything, needs immediate attention and set up a monitoring schedule that continues throughout life.